Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Carlosafine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Carlosafine 35micrograms/hour transdermal patches
0407020B0BTAAAE
|
Carlosafine | Buprenorphine | Central Nervous System | 113 |
|
Carlosafine 70micrograms/hour transdermal patches
0407020B0BTACAG
|
Carlosafine | Buprenorphine | Central Nervous System | 59 |
|
Carlosafine 52.5micrograms/hour transdermal patches
0407020B0BTABAF
|
Carlosafine | Buprenorphine | Central Nervous System | 56 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.